1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Multi-cycle: Mar 21 2025 (cycle 1, closed), Mar 20 2026 (cycle 2, final). Program expires Mar 21 2026. R21 phase then R33 phase.
"Mobile Health (mHealth)" is currently closed and not accepting applications.
Mobile Health (mHealth) is sponsored by NIH Fogarty International Center. This program supports research that uses mobile technologies to improve health outcomes, which could include point-of-care ultrasound diagnostics in global health settings, particularly in Africa.
The Fogarty International Center supports a diverse mix of research projects in Sub-Saharan Africa, with about a third of the funding supporting research on HIV/AIDS and sexually transmitted diseases, and around 20 percent funding research on other infectious diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Mobile Health Technology and Outcomes in LMICs (R21 R33) - Fogarty International Center @ NIH Mobile Health: Technology and Outcomes in Low and Middle Income Countries Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) Non-domestic applicant organizations are restricted to organizations in LMICs, which are defined by The World Bank as low-, lower-middle-, or upper-middle-income economies .
While it is not required (although encouraged) for applications submitted to this NOFO by LMIC institutions to have US partners, all applications submitted to this NOFO by US institutions are required to involve LMIC researchers as key personnel. Program Directors/Principal Investigators may be employed in either a U.S. or LMIC institution, but should plan to build capacity in mHealth research in the LMIC institution(s).
See full Eligibility Information for more details.
Mobile Health: Technology and Outcomes in Low and Middle Income Countries supports exploratory and developmental research to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, or analytics.
The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs.
In the context of this program, mHealth is defined as the use of mobile and wireless devices (cell phones, tablets, etc.) to improve health outcomes, health care services, and health research. The mHealth technology studied in proposed projects may include external hardware and/or software components for mobile or wireless devices. New or emerging technology, platforms, systems, or analytics should be incorporated.
For the purposes of this FOA, research that proposes solely SMS-based text messaging intervention(s) will not be considered responsive. The current funding opportunity announcement provides support for up to two years (R21 phase) for technology development and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for validation, larger-scale feasibility, and effectiveness studies.
Transition to the R33 depends on the completion of applicant-defined milestones, as well as program priorities and the availability of funds. All applicants must address both the R21 and R33 phases. Of highest interest are innovative, well-designed multidisciplinary projects that aim to generate generalizable knowledge for the field.
See the full program announcement for details on the specific research interests of the participating NIH Institutes, Centers and Offices. View a list of mHealth grant awards by institution. Frequently Asked Questions Review answers to frequently asked questions for the Mobile Health: Technology and Outcomes in LMICs Program.
Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 Grants Management Specialist Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 Email: Satabdi. raychowdhury@nih. gov The announcements related to this program are issued by Fogarty in collaboration with the following NIH Institutes, Centers and Offices.
National Cancer Institute (NCI) National Eye Institute (NEI) National Institute of Biomedical Imaging and Bioengineering (NIBIB) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Environmental Health Sciences (NIEHS) National Institute of Mental Health (NIMH) NIH Office of Behavioral and Social Sciences Research (OBSSR) NIH Office of Research on Women's Health (ORWH) mHealth technology enhances the value of Rwanda’s prehospital emergency system Global Health Matters , Sept/Oct 2025 Research in Karachi can help save lives across the globe Global Health Matters , Sept/Oct 2025 These UCLA surgeons are redefining global health Global Health Matters , Sept/Oct 2025 Could a task-sharing tool for hypertension control in Guatemala benefit the US?
Global Health Matters , March/April 2025 Mobile Health Follow-Up Screening to Risk Stratify Patients in Need of Further Care in A Low Resource Setting: Results from A Prospective Multi-Site Implementation Study , co-authored by Fogarty grantees Alain Chichom-Mefire and Catherine Juillard Journal of Trauma and Acute Care Surgery , June 29, 2023 Reproducibility and Relative Validity of a Dietary Screener Adapted for Use among Pregnant Women in Dhulikhel, Nepal , Fogarty grantee Shristi Rawal co-author Maternal and Child Health Journal , September 27, 2022 mHealth app reduces LMIC pregnancy, delivery risks Scientists use mobile health app to mitigate pain in Nepal Focus on mobile health: Developing health solutions to improve health Old mobile phone technology may help curb traffic deaths in Nigeria University of Texas at Dallas news, Feb 13, 2020 Two-way texting study offers innovative model to reduce provider workload while preserving patient safety Innovative mobile health projects in LMICs receive $5M from Fogarty and NIH partners University of Arizona teams building better endoscopes to detect gynecological cancers Arizona Daily Star, Dec 14, 2018 Fogarty awards $4.
4 million to advance mobile health Research boosts mental health task-shifting, innovative approaches , including project in Bolivia supported by Fogarty's mHealth program Texting can enhance medical education in resource-limited settings Boston University news, Feb 27, 2018 Purdue researchers receive grant to improve mobile testing for anemia Purdue University news, Sep 8, 2017 New smartphone attachment detects sickle cell disease Yale News, November 3, 2015 NIH launches new program to spur mobile health innovations Fogarty news, Sep 23, 2014 Fogarty launches program to advance mHealth research Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) (PAR-21-303) Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21 - Clinical Trial Optional) (PAR-18-242) Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) (PAR-16-292) Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) (PAR-14-028) Grants awarded through PAR-14-028 in NIH RePORTER
Key questions and narrative sections extracted from the solicitation.
R21 Specific Aims
R33 Specific Aims
R21/R33 Transition Milestones with quantifiable metrics
Research Strategy
Data Management and Sharing Plan
Resource Sharing Plan
Human Subjects and Clinical Trials Information
Letters of Support from collaborating institutions
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Researchers and institutions. Fogarty International Center provides funding for predoctoral, graduate, postdoctoral, faculty, and health professionals, as well as institutions. Confirm the full requirements in the official notice before applying.
The most recent published deadline was March 20, 2026, which has passed. This is an annual program, so a new cycle should follow. Check the funder's website for the next application window.
Mobile Health (mHealth) is funded by NIH Fogarty International Center. Verify program details on the funder's official page before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The solicitation lists 10 required documents: SF424(R&R) Cover Page, SF424(R&R) Project/Performance Sites, SF424(R&R) Other Project Information, SF424(R&R) Senior/Key Person Profile, SF424(R&R) Budget, and PHS 398 Research Plan (R21 and R33 sections), among others (the full list is in the Required Documents section on this page). Check the official notice for formatting and page-limit rules.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article